Stocks to sell

After a number of data points emerged that are negative for DraftKings (NASDAQ:DKNG) stock, I remain bearish on the shares. DraftKings’ Q1 bottom line was quite worrisome, while its valuation is sky-high. In several past columns, my thesis has been that the U.S. sports gambling market would be hyper-competitive. Validating that thesis is a report

Is there still hope for Ocugen (NASDAQ:OCGN)? Or are the OCGN stock bulls just delusional? In my view, you can count on the latter. Any way you slice it, this biotech company has little chance of generating big profits — or even big sales — from its Covaxin Covid-19 vaccine candidate. Source: Shutterstock As you

After losing its luster this spring and declining sharply, Tesla (NASDAQ:TSLA) stock is struggling to get back in the good books with investors. Source: Grisha Bruev / Shutterstock.com Year-to-date, TSLA stock is down 7% at its current price of  around $679 a share. The company’s stock is 24% below its 52-week high of $900 reached

Clean Energy Fuels (NASDAQ:CLNE) reminds me of another company that briefly became extremely popular among retail investors: Gevo (NASDAQ:GEVO). The shares of both GEVO stock and CLNE stock are now about 50% off their 52-week highs and have generated mediocre returns in recent weeks , as many investors apparently started to realize that neither of

Lordstown Motors (NASDAQ:RIDE) stock is becoming a cautionary tale for many investors in electric vehicle (EV) stocks. Source: Postmodern Studio / Shutterstock.com RIDE stock is down almost 50% in 2021. And that was the case before the company announced that its “backlog” of pre-orders do not represent binding commitment.   That announcement came on the heels of top

The outlook of Carnival Corporation (NYSE:CCL) stock has improved in recent weeks, but given the cruise operator’s extremely high debt load and the great amount of uncertainty it continues to face, I still urge investors to sell their shares. Source: Ruth Peterkin / Shutterstock.com In addition to its highly elevated debt load, Carnival must deal

At just under $60 per share, what’s the play with AMC Entertainment (NYSE:AMC) stock? Is it a buy? Not so fast. Source: viewimage / Shutterstock.com Sure, retail speculators, led by Reddit’s r/WallStreetBets, have so far prevailed against the so-called “smart money” short sellers. On the other hand, in terms of underlying value and long-term prospects,

The party’s over once again for Clover Health (NASDAQ:CLOV) stock. A few months back, the insurtech company, and former SPAC (special purpose acquisition company), was a popular health care-related “story stock.” Source: Shutterstock News of a Department of Justice (DOJ) investigation fueled a big change in investor’s opinions about it. But starting in the spring,

ContextLogic (NASDAQ:WISH) stock went public last December. After a brief pop, the share price fell to single digits in May. Source: sdx15 / Shutterstock.com It fell because ContextLogic loses money. Its first quarter report showed a loss of $128 million, 21 cents per share, on revenue of $772 million. Losses from operations, $126 million, grew

I’m sure many investors in AMC Entertainment (NYSE:AMC) have stopped reading this article just based on the headline. And others are ready to tell me I don’t get it. So let me be clear. When it comes to AMC stock, I understand your point. I just disagree with it.   Source: QualityHD / Shutterstock.com In 2021, AMC stock is at its

Workhorse (NASDAQ:WKHS) reported very weak first-quarter results and  appears to have no viable, strong, upcoming, positive catalysts. WKHS stock is in trouble. Source: Shutterstock The EV maker’s inability to win any major deals or recruit any impressive partners so far, its apparent failure to cash in on opportunities with the U.S. Post Office and UPS

Health insurance company Clover Health (NASDAQ:CLOV) went public via the SPAC route in January, and since then, its stock has been on a wild ride. CLOV stock became the latest target of the Reddit retail trading crowd, causing Clover’s share  price to reach new highs. Source: Shutterstock Unfortunately, the stock is now overvalued, and Clover’s

I’ve been wrong twice about DraftKings (NASDAQ:DKNG) stock. I may be again. In June 2020, six months after DraftKings came public, I warned people to look out below. At the time the stock was at $42/share. It has since traded for as much as $72/share. In January 2021 I suggested there was still time to

Clover Health (NASDAQ:CLOV) stock is up 57% in the last month. The price action highlights the uncertainty of investing in celebrity SPAC (special purpose acquisition company) plays. Source: Shutterstock Bit of background here. Venture capitalist and resident SPAC king Chamath Palihapitiya helped Clover, which sells Medicare-backed insurance plans, to go public through a $3.7 billion deal

Bionano Genomics (NASDAQ:BNGO) stock might appear interesting at first blush. After all, the company has developed an optical DNA mapping instrument called Saphyr. It is a high throughput system – which looks like a printer from the outside – that allows genome variations to be rapidly identified.  Source: Connect world / Shutterstock.com However, upon taking

Canoo (NASDAQ:GOEV) released its earnings on May 17 and made some concerning statements. Expect GOEV stock to drive lower. Source: Shutterstock For starters, the company is no longer going to use a contract manufacturer. It also expects to take until 2023 before electric vehicle (EV) deliveries and revenue begin to flow into the company. More troubling

MicroVision is still up for sale, just like the CEO said it was and the latest 10-Q report indicates. Unfortunately, there are still no buyers. Source: Shutterstock For some reason, the market thinks a deal will happen when the stock is at a market value of $3.41 billion. Allow me to provide an evidently-needed reality

Fisker (NYSE:FSR) detailed ongoing operating and capital spending plans in its latest Q1 earnings release on May 17. A capital raise looks likely for the electric vehicle (EV) car maker, and likely to wreak havoc on FSR stock, at least until investors have visibility on when, exactly, they can expect Fisker to start producing free

Since the beginning of the year, shares of Cyprus-based shipping company Castor Maritime (NASDAQ:CTRM) stock are up by more than 80%. Source: Pavel Kapysh / Shutterstock.com As stated in its filings with the SEC back in April, its recent stock increases were “significantly inconsistent” with its performance. It continues to expand its fleet aggressively, putting

There’s been plenty of talk about GameStop (NYSE:GME) stock going to the moon in 2021. At the same time, there’s been plenty of people pounding the table that the stock is overvalued. Source: Northfoto / Shutterstock.com For sure, GME stock is overvalued compared to where it was just a year ago. The stock is up